Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents
about
Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myelomaSecondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.oligoclonal bands in patients with multiple myeloma: its emergence per se could not be translated to improved survivalImmunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution.Response evaluation and monitoring of multiple myeloma.Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival.Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results.Capillary electrophoresis/immunosubtraction as a better alternative to immunofixation for detecting and immunotyping serum monoclonal proteins in patients with immunoglobulin light chain (AL) amyloidosis.Oligoclonal Bands of Immunoglobulins in Serum Leading to Diagnosis of Human Immunodeficiency Virus 1 Infection.Lack of correlation between emergence of an abnormal protein band or of oligoclonal bands and survival in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation.For survival, the emergence of oligoclonal bands after multiple myeloma treatment is less important than achieving complete remission.
P2860
Q34454581-35B10A03-341B-41A9-8189-3D886D6F4776Q34649034-C8549552-C023-4C85-BD39-2D6BBE85EB36Q35713418-12A40F25-527F-418F-B2E1-1DD0653E1D06Q36525219-13A4420C-3439-43A7-8E63-8BE4A2545475Q36967163-F236D88F-984B-4CE3-88C6-18C3918BCEC1Q38183872-548936F1-6771-4632-9ACB-2B959757205CQ38310281-3B58CA52-EECD-4582-BBAC-A9D1D6D3FDF5Q38316150-FF626E88-27EF-46F5-B1D5-74C144412D35Q38671274-7D36775D-CAD8-43C3-813A-2522C41DD89EQ39341586-6AA2A80A-946F-4F34-A2C0-ABB1D645E543Q40809257-679A2BDC-4ED7-490B-ADFE-24F8923D9A1AQ42708678-4CFC352F-90FF-4167-87A8-75E8C9B1928FQ47390705-B3D69A54-902A-41D1-B8B6-F2E025A4AD81
P2860
Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Emergence of oligoclonal bands ...... n with the use of novel agents
@ast
Emergence of oligoclonal bands ...... n with the use of novel agents
@en
Emergence of oligoclonal bands ...... n with the use of novel agents
@nl
type
label
Emergence of oligoclonal bands ...... n with the use of novel agents
@ast
Emergence of oligoclonal bands ...... n with the use of novel agents
@en
Emergence of oligoclonal bands ...... n with the use of novel agents
@nl
prefLabel
Emergence of oligoclonal bands ...... n with the use of novel agents
@ast
Emergence of oligoclonal bands ...... n with the use of novel agents
@en
Emergence of oligoclonal bands ...... n with the use of novel agents
@nl
P2093
P2860
P1433
P1476
Emergence of oligoclonal bands ...... n with the use of novel agents
@en
P2093
Carlos Fernández de Larrea
Joan Bladé
Jordi Yagüe
Laura Rosiñol
M Teresa Cibeira
Montserrat Elena
Natalia Tovar
Xavier Filella
P2860
P304
P356
10.3324/HAEMATOL.2010.030882
P577
2010-09-30T00:00:00Z